684 related articles for article (PubMed ID: 19056840)
41. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
[TBL] [Abstract][Full Text] [Related]
42. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
43. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
Crandall C
J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
[TBL] [Abstract][Full Text] [Related]
44. Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Baber R; Hickey M; Kwik M
Drug Saf; 2005; 28(12):1085-100. PubMed ID: 16329712
[TBL] [Abstract][Full Text] [Related]
45. Can we predict who will experience recurrent vasomotor symptoms after stopping hormone therapy?
Gracia CR; Sondheimer S
Menopause; 2010; 17(1):10-1. PubMed ID: 20010441
[No Abstract] [Full Text] [Related]
46. Current trends in hormone replacement therapy.
Khashoggi TY
Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
[TBL] [Abstract][Full Text] [Related]
47. Use of alternatives to estrogen for treatment of menopause.
Pinkerton JV; Santen R
Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111
[TBL] [Abstract][Full Text] [Related]
48. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.
Simon JA; Snabes MC
Expert Opin Investig Drugs; 2007 Dec; 16(12):2005-20. PubMed ID: 18042008
[TBL] [Abstract][Full Text] [Related]
49. Practice patterns with hormone therapy after surgical menopause.
Chubaty A; Shandro MT; Schuurmans N; Yuksel N
Maturitas; 2011 May; 69(1):69-73. PubMed ID: 21396791
[TBL] [Abstract][Full Text] [Related]
50. Ultra-low dose - new approaches in menopausal hormone therapy.
Stute P; Becker HG; Bitzer J; Chatsiproios D; Luzuy F; von Wolff M; Wunder D; Birkhäuser M
Climacteric; 2015 Apr; 18(2):182-6. PubMed ID: 25335192
[TBL] [Abstract][Full Text] [Related]
51. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
Carroll N
J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
[TBL] [Abstract][Full Text] [Related]
52. Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors.
Santen RJ; Stuenkel CA; Davis SR; Pinkerton JV; Gompel A; Lumsden MA
J Clin Endocrinol Metab; 2017 Oct; 102(10):3647-3661. PubMed ID: 28934376
[TBL] [Abstract][Full Text] [Related]
53. Hormone therapy -- where are we now?
Teede HJ; Vincent A
Aust Fam Physician; 2011 May; 40(5):280-5. PubMed ID: 21597544
[TBL] [Abstract][Full Text] [Related]
54. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
55. Menopausal symptoms in older women and the effects of treatment with hormone therapy.
Barnabei VM; Grady D; Stovall DW; Cauley JA; Lin F; Stuenkel CA; Stefanick ML; Pickar JH
Obstet Gynecol; 2002 Dec; 100(6):1209-18. PubMed ID: 12468165
[TBL] [Abstract][Full Text] [Related]
56. Role of hormone therapy in the management of menopause.
Shifren JL; Schiff I
Obstet Gynecol; 2010 Apr; 115(4):839-855. PubMed ID: 20308847
[TBL] [Abstract][Full Text] [Related]
57. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
Umland EM
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):14-9. PubMed ID: 18439062
[TBL] [Abstract][Full Text] [Related]
58. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
59. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
60. Management of Menopausal Symptoms.
Kaunitz AM; Manson JE
Obstet Gynecol; 2015 Oct; 126(4):859-876. PubMed ID: 26348174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
